![]() |
|
|
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
![]() |
|
Human KLRD1 / CD94 | |
Mouse | |
Human (tested or 100% immunogen sequence identity) | |
IgG1 Monoclonal | |
Unconjugated. Also available conjugated with AP, Biotin, FITC, HRP, PE. | |
Protein G purified | |
Unmodified |
KLRD1 / CD94 antibody was raised against natural killer cell line. | |
Specific for human CD94. Reported to inhibit the binding of CD94 to HLA-E and HLA-G. | |
Flow Cytometry: Use 10 ul of the suggested working dilution to label 1 x 1E6 cells in 100ul. Recommended Secondary Reagents: F (ab')2 Rabbit anti mouse IgG: FITC. F (ab')2 Rabbit anti mouse IgG: RPE. Recommended Negative Controls: Mouse IgG1 Negative Control. |
PBS, pH 7.2, 0.1% sodium azide. | |
Short term: +4°C; Long term: Add glycerol (40-50%) -20°C. | |
For research use only. |
KLRD1 Antibody, CD94 Antibody, KP43 Antibody, NK cell receptor Antibody, CD94 antigen Antibody
Natural killer (NK) cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus.